[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Academy Training
  • Bespoke Training
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us

Online Pharmacy – are patients better with a ‘face to face’?

by Jackie (née Heneghan) Peck | Jun 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Regulation

Recent coverage in the Australian community pharmacy press has centred around the benefit and/or potential harm of prescribing and dispensing medicines without a face-to-face consultation.  The discussion raised asked the question whether an online questionnaire is...

Recent MHRA Alerts

by Jackie (née Heneghan) Peck | May 20, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

So much for all the wonders and claims of slimming tablets … After investigation, the MHRA has recently issued alerts about a number of products found to have prescription only drug ingredients in them.  All the alerts were raised by the Hong Kong Department of...

Export of medicines in short supply………

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers

The PSNC is no longer maintaining a list as shortages have become part of every day life in pharmacy now. This posed a question by one of my clients: “Does this mean we can now export anything?” No I said you must not export drugs in short supply and I refereed him to...

RP & GDP Training for WDA(H)

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

RP – Responsible Person relating to MHRA GDP – Good Distribution Practice – the guidelines by which medicine wholesalers must adhere to WDA(H) – Wholesale Distribution Authorisation for Human Use – previously Wholesale Dealer’s...

Out of Specification (OOS) Test Results

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Pharmacy Suppliers, Regulation

What are Out of Specification results (OOS)?  It seems to be clear enough in the name but I thought I better check it out. One definition is: All test results which fall outside the specifications or acceptance criteria established in drug applications, drug master...

Wholesale Dealer or Distributor? Wholesale Licence or Authorisation?

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog

Which one do you have? I know we now have to have a wholesale distribution authorisation (WDA ) to wholesale medicines but I still find myself saying wholesale dealers licence and wholesale dealers authorisation. Why the change? We have to come into line with the rest...

Today’s thought – small business

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Community Pharmacy, Pharmacy Suppliers

So here’s my rant for the day … it reflects just some of the difficulties of being a small business owner! It is a crazy old world in the same month I have had a letter form David Cameron, telling me he is  saving me £2000 in NI contributions this year and...

Quality Agreements- Technical Agreements- Good ones are invaluable!

by Jackie (née Heneghan) Peck | May 12, 2014 | Blog, Pharmacy Brands, Pharmacy Suppliers, Regulation

TAs – when do we need them in place and who with and what should be in them? PCL have been reviewing a few TAs over the last few weeks and we have put a few tips and hints together. If you only follow GDP or GMP; the principals are the same. If you are a...

The current state of Pfizer

by Jackie (née Heneghan) Peck | May 12, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

Pfizer’s bid for AstraZeneca scrutinised – should it be only the shareholders who decide? AstraZeneca employs over six thousand people in the UK. Pfizer has made nine promises in a letter to David Cameron which are said to reflect Pfizer’s commitment to the UK....

Responsible Person for Wholesaling – MHRA

by Jackie (née Heneghan) Peck | May 11, 2014 | Behind the scenes, Blog, Community Pharmacy, Pharmacy Brands, Pharmacy Suppliers, Regulation

If you’re applying for a new Wholesale Distribution Authorisation – WDA(H) – you will need to have a Responsible Person or RP registered to the Authorisation.  This person needs to be approved and registered by the MHRA. As a new wholesaler you can...
« Older Entries
Next Entries »

Recent Posts

  • Heatwaves, Medicines and the Leadership Imperative
  • Climate Change Is Creating a New Challenge for Medicines Storage
  • Newly qualified prescribing pharmacists

Upcoming Courses

  • Export Online Training on 8 September 2026 10:00 am
  • Understanding GPhC Guidance for Online Pharmacies – Online Training on 9 September 2026
  • GDP/RP Cogent Gold Standard Online Training on 15 September 2026
  • GDP Audit Online Training on 18 September 2026 10:00 am
  • Introduction to Good Distribution Practice Online Training on 30 September 2026 10:00 am

MHRA Alerts & Recalls

Rectal catheters sold for personal use (gas and colic relievers): Do not use in infants, including for the treatment of colic, gas-related discomfort or constipation (DSI/2026/008)
20 August 2026
Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37
20 August 2026
Field Safety Notices: 10 to 14 August 2026
18 August 2026
Field Safety Notices: 13 to 17 July 2026
18 August 2026

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow